1260833-40-6

Basic information

• Product Name: 5-bromo-2-(cyclobutyloxy)Pyrimidine
• Synonyms: 5-bromo-2-(cyclobutyloxy)Pyrimidine
• CAS NO: 1260833-40-6
• Molecular Weight: 229.076
• Mol File: 1260833-40-6.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 5-bromo-2-(cyclobutyloxy)Pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-2-(cyclobutyloxy)Pyrimidine(1260833-40-6)
• EPA Substance Registry System: 5-bromo-2-(cyclobutyloxy)Pyrimidine(1260833-40-6)

Safety Data

• Hazardous Substances Data: 1260833-40-6(Hazardous Substances Data)

Upstream product

• 2919-23-5 cyclobutanol 
• 32779-36-5 5-Bromo-2-chloropyrimidine 

Downstream Products

• 1646268-09-8 (2-cyclobutoxypyrimidin-5-yl)boronic acid 

Relevant articles and documents

6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS

The present invention provides compounds of Formula (I): and pharmaceutically acceptable salts thereof wherein the variables R1, R2, R3, R4, R5, a and A are as defined herein; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D3-mediated (or D3-associated) disorders including, e.g., substance addiction, substance abuse, schizophrenia (e.g., its cognitive symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD or PD), Parkinson's disease, mania, anxiety, impulse control disorders, sexual disorders and depression.

NEW AZIRIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS ACETYL-COA CARBOXYLASE INHIBITORS

The invention relates to new azetidine derivatives of the formula (I) wherein Ar1, Ar2, X, R, T and L are as defined in the description, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

New azetidine derivatives, pharmaceutical compositions and uses thereof

The invention relates to new azetidine derivatives of the formula I to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.